Why should Mobility DC provide any benefit?
Mobility DC provides two joint protective supplements, hyaluronic acid and chondroitin. Hyaluronic acid is the most important compound in the synovial fluid to maintain joint health and mobility. In addition, the benefits of chondroitin are dependent on the presence and concentration of hyaluronic acid.
Are there any known side-effects associated with the use of the supplement?
As with any product, individual pets can have a possible minor ailment, such as diarrhea. However, there has been no serious adverse side-effects reported.
Is it safe to use the supplement with other medications?
There have been no reports of adverse drug interactions with other product. Discontinue use and consult your veterinarian if any adverse reactions occur.
Is the supplement stimulant free and can be safely used by competitive dogs?
The supplement does not contain any stimulants and can be used by competitive dogs.
What is the most appropriate time for an active dog to use the supplement?
It is recommended to take the supplement prior to a period of intense activities. This will give maximum opportunity for the product to support joint health. This dosage should be repeated in 6 months to support synovial fluid health.
Is there an ideal time during the day to take the product?
The supplement can be taken at any time during the day.
Does the supplement immediately relieve lameness and joint pain?
No, the supplement is not an analgesic. Clinical studies have demonstrated improvement in joint health and mobility commences 7-10 days after the initial dose.
Why do we need to supplement hyaluronic acid in companion animals?
The body’s natural production of hyaluronic acid starts to decline as the pet ages. With a very active dog, the quality and viscosity of the dog’s synovial fluid declines which can be responsible for joint problems. Therefore, supplementation of hyaluronic acid can be very important to support joint health.
How often should a 30-day treatment course of Mobility DC be administered?
This is very much dependent on the condition of the joints and the extent of degenerative joint disease. In most cases, twice yearly is sufficient. Where there is extensive degenerative disease, an initial treatment course of 60-90 days may be required. It may be necessary to repeat this treatment schedule every 9-12 months. For younger, active dogs where you are looking to promote joint health and mobility, who are not experiencing symptoms, once yearly could be sufficient.
Arthritis is one of the most common conditions that effect dogs. In fact, arthritis is believed to occur in 20-25% of all dogs. It is the most common pain veterinarians treat.
What joints in a dog are most affected?
The joints most often affected by arthritis include the hips, knees and elbows.
Is arthritis related to aging of the dog?
Arthritis can occur in dogs of all ages, although it tends to appear in the second half of their lives.
Are certain dogs more prone to developing arthritis?
Yes, large and heavy dogs are more likely to suffer from arthritis as their body grows quickly and they participate in more intense physical activities. However, arthritis can affect dogs of any breed or size. Dogs such as dachshunds, bulldogs and basset hounds have skeletal problems caused by genetic disorders that affect the development of cartilage making them predisposed to joint and cartilage disease.
What breeds are more likely to develop arthritis?
What is osteoarthritis?
Osteoarthritis is a chronic degenerative disease due to gradual progressive damage to the joint characterized by:
Articular cartilage is a smooth viscoelastic tissue that covers the joints and is responsible for the mechanical distribution of loads across the joints and aids in the motion of the joints. Once damaged, it does not have the capacity to heal itself.
Chondroitin sulphate is a naturally produced substance in the body. It is a major component of many connective tissues including cartilage. Also, it is responsible for many of the important biomechanical properties of the cartilage, including resistance and elasticity. It has a high fluid binding capacity, helping maintain elasticity and shock absorbing properties.
What is Hyaluronic Acid?
Hyaluronic Acid, also called hyaluronan is a naturally occurring carbohydrate in the human body. It acts as a cushioning and lubrication agent for our joints, nerves, hair, skin, and eyes.
The body requires supplementation of hyaluronic acid as with aging the body's ability to produce hyaluronic acid declines. In humans by the age of 40, the hyaluronic acid production has already decreased by 50% and by age 60 it has declined to 10% of the original production.
With insufficient nutrition, due to reduced hyaluronic acid production the cartilage cells die and the cartilage degenerates thus losing its function and then inflammation and the start of degenerative joint disease. Duo-Vital has been formulated at an optimal molecular mass to allow absorption through the digestive tract and subsequent release into the blood circulation to provide support for all joints in the body. Hyaluronic acid is sometimes administered by injection but only provides relief to the injected joint if it is injected correctly
Synovial fluid is principally comprised of hyaluronic acid found in the joint capsules. It has two main functions; aids in the nutrition of cartilage by transporting nutrients and aids in the mechanical functioning of the joints by lubricating the moving surfaces and cushioning and protecting the joints.
Is chondroitin effective in supporting joint health?
According to recommendations of the European League Against Rheumatism and the Osteoarthritis Research Society International (OARSI), chondroitin provides medium strong up to strong relief of pain and an increase of the joint functionality. At the same time, it was proven that the effectiveness of chondroitin depends on the presence and concentration of hyaluronic acid.
Are supplements containing glucosamine and chondroitin effective in providing joint support?
There are conflicting results reported on the effectiveness of chondroitin and glucosamine supplements. An evaluation of studies conducted on 3,803 patients using glucosamine, chondroitin and the combination of the two concluded that estimated treatment effects in industry independent trials were small or absent and clinically irrelevant. This study conducted by Simon Wandel et. al. from the Institute of Social and Preventive Medicine, University of Bern, Switzerland was published in the BMJ.